New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro

Journal of Neuroscience Research

Volumn 51, Issue 2, 1998, Pages 218-222

  James, T ^a   Matzelle, D ^a   Bartus, R ^b   Hogan, E L ^a   Banik, N L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ALKERMES INC   (United States)

Author keywords

Calpain; Calpastatin; Myelin basic protein; Neurofilament protein; Neuroprotection; Spinal cord injury

Indexed keywords

AK 275; AK 295; CALPAIN; CALPASTATIN; CALPEPTIN; CYTOSKELETON PROTEIN; MYELIN BASIC PROTEIN; MYELIN PROTEIN; NEUROFILAMENT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; CYTOSKELETON; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RAT; SPINAL CORD INJURY;

ANIMALS; CALPAIN; CASEINS; CYSTEINE PROTEINASE INHIBITORS; CYTOSKELETAL PROTEINS; DIPEPTIDES; ENZYME INHIBITORS; HALF-LIFE; MYELIN PROTEINS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0032518488     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980115)51:2<218::AID-JNR10>3.0.CO;2-4     Document Type: Article

References (35)

1. Banik NL, Hogan EL (1994): Role of membrane calpain in biological function. In Malhotra JK (ed): "Advances in Structural Biology." Greenwich, CT: JAI Press, vol III, pp 17-46.
2. Banik NL, Chakrabarti AK, Hogan EL (1990): Purification of an endogenous 68 kDa inhibitor of calcium-activated neutral proteinase (CANP) from bovine brain: Immunoblot identification and characterization. J Neurosci Res 25:119-124.
3. Banik NL, Chakrabarti AK, Hogan EL (1992): Role of calcium-activated neutral proteinase in myelin: Its role and function. In Martenson R (ed): "Myelin, Biology and Chemistry." Caldwell, NJ: Telford Press, pp 571-597.
4. Banik NL, Lobo D, Gantt-Wilford G, Hogan EL (1995): Increased calpain activity and expression in spinal cord injury. J Neurochem 65(Suppl 1):S43B.
5. Bartus RT (1997): The calpain hypothesis of neurodegeneration: Evidence for a common cytotoxic pathway. Neuroscientist 3:314-327.
6. Bartus R, Baker KL, Keiser AD, Sawyer SD, Dean RL, Elliott PJ, Straub JA (1994): Post-ischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J Cereb Blood Flow Metab 14:537-544.
7. Bartus R, Heyward NJ, Elliott PJ, Sawyer SD, Dean RL, Dean RL, Akiyuama A, Straub JA, Harbeson SL, Li Z (1995a): Calpain inhibitor AK295 protects neurons from focal brain ischemia: Effects of post-occlusion intra-arterial administration. Stroke 25:2265-2270.
8. Bartus RT, Dean RL, Cavanaugh K, Eveleth D, Carriero DL, Lynch G (1995b): Time-related neuronal changes following middle cerebral artery occlusion: Implications for therapeutic intervention and the role of calpain. J Cereb Blood Flow Metab 15:969-979.
9. Chakrabarti AK, Banik NL, Powers JM, Hogan EL (1989): The regional and subcellular distribution of calcium-activated neutral proteinase (CANP) in the bovine central nervous system. Neurochem Res 14:259-266.
10. Chakrabarti AK, Dasgupta S, Banik NL, Hogan EL (1990a): Regulation of the calcium-activated neutral proteinase (CANP) of bovine brain by myelin lipids. Biochim Biophys Acta 1038:195-198.
11. 2+-activated neutral proteinase (CANP): A role for glycoconjugates in CANP regulation. J Neurochem 54:1816-1819.
12. 2+ level. J Neurosci Res 44:374-380.
13. 2+-dependent proteinases (μ-calpain and m-calpain). J Biol Chem 264:10096-10103.
14. 2+ requirement for autolysis. J Biol Chem 259:11627-11630.
15. Croall DE, DeMartino GN (1990): Regulation of calcium-dependent protease activity in vitro. In Mellgren RL, Murachi T (eds): "Intracellular Calcium-Dependent Proteolysis." Boca Raton, FL: CRC Press, pp 103-114.
16. Deibler GE, Martenson RE, Kies MW (1972): Large scale preparation of myelin basic protein from central nervous system tissue of several mammalian species. Prep Biochem 2:139-165.
17. Figueiredo-Pereira ME, Banik NL, Wilk S (1994): Comparing the effect of calpain inhibitors on two extralysosomal proteinases: The multicatalytic proteinase complex and mcalpain. J Neurochem 62:1989-1994.
18. Imajoh S, Kawasaki H, Suzuki K (1986): The amino-terminal hydrophobic region of the small subunit of calcium-activated neutral protease (CANP) is essential for its activation by phosphatidylinositol. J Biochem 99:1281-1284.
19. Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T. Nature 227:680-685.
20. Lee KS, Frank S, Vanderlisk P, Arai A, Lynch G (1990): Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci USA 88:7233-7237.
21. McGowan EB, Becker E, DetwilerTC (1989): Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64d. Biochem Biophys Res Commun 158:432-435.
22. Mehdi S (1991): Cell penetrating inhibitors of calpain. Trends Biochem Sci 16:150-153.
23. Mohan PS, Nixon RA (1995): Purification and properties of high molecular weight calpastatin from bovine brain. J Neurochem 64:859-866.
24. Murachi T (1989): Intracellular regulatory system involving calpain and calpastatin. Biochem Int 18:263-294.
25. Nixon RA, Saito KI, Grynspan F, Griffin WR, Katayama S, Honda T, Mohan PS, Shea TB, Beermann M (1994): Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann NY Acad Sci 747:77-91.
26. Posmantur R, Hayes RL, Dixon CE, Taft WC (1994): Neurofilament 68 and neurofilament 200 protein levels after traumatic brain injury. J Neurotrauma 11:533-545.
27. Saatman KE, Murai H, Burtus RT, Smith DH, Hayward NJ, Perri BR, McIntoshTK (1996): Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc Nat Acad Sci USA 93:3428-3433.
28. Saito KI, Nixon R (1993): Specificity of calcium-activated neutral proteinase (CANP) inhibitors for human μCANP and mCANP. Neurochem Res 18:231-233.
29. Shearer T, David LL (1990): Calpains in lens and cataract. In Mellgren RL, Murachi T (eds): "Intracellular Calcium-Dependent Proteolysis." Boca Raton, FL: CRC Press, pp 265-276.
30. Shields D, Deibler GE, Banik NL (1997): Calpain, a mediator in demyelinating diseases. Ann NY Acad Sci (in press).
31. Siman R, Noszek JC (1988): Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1:279-287.
32. Suzuki K, Imajoh S, Emori Y, Kawasaki H, Minami Y, Ohno S (1987): Calcium-activated neutral protease and its endogenous inhibitor: Activation at the cell membrane and biological function. FEBS Lett 220:271-277.
33. Tamai M, Omura S, Kimura M, Hanada K, Sugita H (1987): Prolongation of life span in dystrophic hamster by cysteine protease inhibitor, loxistatin (EST). J Pharmacobiodyn 10:678-681.
34. Towbin H, Stachlin T, Gordon J (1979): Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
35. Tsujinaka T, Kajiwara Y, Kambayashi J, Sakon M, Mori T (1988): Studies on myosin light chain phosphorylation in intact platelets, utilizing cell penetrating thiol protease inhibitor. Thromb Res 51:365-372.